Answers are grounded in this paper and cite their sources.
This study reviewed transcripts of meetings of the Oncologic Drugs Advisory Committee to the US Food and Drug Administration to characterize potential financial and other conflicts of interest of public speakers.
No takes yet. Share an insight, caveat, or question.
Abola et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: